VALLON PHARMACEU(VLON) - 2025 Q4 - Annual Results

Financial Results - GRI Bio, Inc. reiterated its financial results for the fiscal year 2025 on February 4, 2026[4]. Company Classification - The company is classified as an emerging growth company under the Securities Act of 1933[3]. Recent Highlights - A press release summarizing key recent highlights was issued, which is attached as Exhibit 99.1[4].